Quarterly ResultJul 30, 2026, 08:31 AM
Graham Holdings Q2 Basic EPS $65.53, up 677%; Revenue up 7.1%
AI Summary
Graham Holdings reported strong second-quarter 2026 results, with basic EPS soaring to $65.53, a 677% increase year-over-year, and operating revenues rising 7.1% to $1.30 billion. The company completed the divestment of its Kaplan Languages Group business in May 2026, incurring a $5.2 million non-operating loss and a $19.0 million impairment charge in Q1. Graham Holdings also acquired a small healthcare business and increased its stake in CSI Pharmacy for $41.0 million, while repurchasing $122.0 million in common shares year-to-date.
Key Highlights
- Q2 2026 Basic EPS increased 677.3% to $65.53 from $8.43 in Q2 2025.
- Q2 2026 Operating Revenues rose 7.1% to $1.30 billion from $1.22 billion in Q2 2025.
- Net income attributable to common stockholders surged 664.9% to $281.1 million in Q2 2026.
- Kaplan completed the sale of its KLG business in May 2026, resulting in a $5.2 million non-operating loss.
- Company recognized $19.0 million in impairment charges related to KLG in Q1 2026.
- Acquired minority-owned shares of CSI for $41.0 million in March 2026.
- Repurchased $122.0 million of common shares year-to-date through June 30, 2026.
- Recorded a $5.8 million impairment on its investment in Realm in Q2 2026.
Price Impact
More from GHC